Peter Salzmann
Algemeen Directeur bij IMMUNOVANT, INC.
Vermogen: 29 M $ op 30-04-2024
Actieve functies van Peter Salzmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Bestuurslid | 06-03-2020 | - |
| Independent Dir/Board Member | 06-03-2020 | - | |
| IMMUNOVANT, INC. | Directeur/Bestuurslid | 01-10-2019 | - |
| Algemeen Directeur | 01-06-2019 | - | |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Directeur/Bestuurslid | - | - |
| IMVT Corp. | Algemeen Directeur | - | - |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Directeur/Bestuurslid | 01-10-2019 | - |
Loopbaan van Peter Salzmann
Eerdere bekende functies van Peter Salzmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-01-2011 | 01-06-2019 |
| Eli Lilly Asia, Inc. | Verkoop & Marketing | 01-01-2008 | 01-12-2010 |
Opleiding van Peter Salzmann
| Northwestern University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| Pritzker School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| China | 2 |
| Bermuda | 2 |
Operationeel
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Health Technology |
| Eli Lilly Asia, Inc. | |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Health Technology |
| IMVT Corp. |
- Beurs
- Insiders
- Peter Salzmann
- Ervaring
